Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
about
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infectionExamination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.Links between complement abnormalities and systemic lupus erythematosus.Studies of a hypomorphic variant of human C3Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.Specific secondary biological properties of purified rabbit immunoglobulin M and immunoglobulin G antibodies to Brucella abortus and Bordetella pertussisEffect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edemaGenetic polymorphism of the third component of human complement (C'3).In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemiaCirculating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.The serum concentration of the third component of complement beta-1C-beta-1A in liver diseaseMetabolism of properdin in normal subjects and patients with renal disease.Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.Complement and systemic lupus erythematosus.Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk.The immunological basis of glomerulonephritis.Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.A quantitative lateral flow assay to detect complement activation in bloodHuman prothrombin metabolism in normal man and in hypocoagulable subjectsComplement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.Simple measurement of serum beta-1-C globulin in children with kidney disease.Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1.Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.Therapeutic control of complement activation at the level of the central component C3.[Pathophysiology and clinical data of complement].Complement in nephritis.Acute local inflammation alters synthesis, distribution, and catabolism of third component of complement (C3) in rabbits.Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.Inactivator of the third component of complement as an inhibitor in the properdin pathway.Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.Inherited deficiency of the third component of human complement (C'3).Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?Complement and the kidney
P2860
Q24300424-E52E86DF-FFBD-4EED-97D5-6608583001BBQ33551324-BBE03BD0-BD80-45F8-857A-6A776FF56ED6Q33556592-4D3BCDD1-2311-47CD-8320-270F38966AE0Q33569703-365B809C-D5DC-4013-934A-CE25E096B385Q33867927-484EB660-3B88-47D5-9226-7E44DACCB1B4Q34056489-85F4F2A4-9DB1-4464-9F0C-892C8B2AD802Q34057909-FD474B99-DE16-4940-867F-BADCFE80D02CQ34174113-6BAD564B-A549-4F2C-BC34-6335FD2D4850Q34272964-DB259B1E-DBF7-495E-BECA-F7F3A6DB5E0AQ34278770-ED2D396A-090D-4A4F-B60F-0AE8DFD461F0Q34280252-3B9C614C-F866-4693-9F90-3863E2ED13E8Q34464705-9652F0CC-7C75-49E0-AD24-1A8F1B10461BQ34473951-57B11CF2-7834-4A49-B525-BE1E64D8924FQ34482222-71DCCFD5-516A-4497-ADB3-AD1867A1E58FQ34499642-9E3698A1-ECF7-492F-A032-B755D302371EQ34502559-AE40E3D7-2888-4DD0-9CA0-103714638EE5Q34731255-475D0407-0254-454F-91C7-A4A944E7DF4EQ35142386-AF3E1C0E-EBC5-476B-8251-6922D4101A95Q35144909-6DC52482-EAE5-4179-9582-0D1DE128CC9CQ35194351-4509B285-1F06-434F-8096-7F1F8349C03DQ35196708-2EFE4B38-F919-4F7C-9A15-FEF3CAA34591Q35201919-A8103947-A908-47AD-89D2-F66E7FF0CD4AQ35205999-C7951C3F-8D0B-422A-B39F-0F85694365BCQ35498749-9DC19161-6E43-45EB-B974-18BA67E9EB55Q35571574-5FF04B9C-2C43-412F-9AD6-2655F81EB6C2Q35572234-82A9C96B-23CE-4763-9B1E-C8EF06A06D41Q35824467-7043C1B9-A95F-4404-AF4A-A1ABF10DB1C2Q35909399-9E4F3662-7459-41B2-BD30-18EFE2F7A69FQ36270181-4980FEF2-4CB1-49B1-A38B-D52F15FC9055Q36270397-95DFF94D-E164-4D6F-9F7F-3788B0AB980EQ36363005-BD3D3B8F-5F91-442E-A9D9-7220B2BAF4FDQ36535725-D539970C-FCDE-45AC-81B5-908E6B021148Q36810294-B7850FE6-17D6-4B5F-88FD-AFEAC08E8BA6Q36992787-5E8653FD-C249-4573-8069-17BD4298418EQ37043934-B3132709-1AAC-4D1B-8BAA-5255C3979493Q37496999-E5C6D042-B9B3-4FDA-A6E5-525C59AA7E4EQ37670073-237B0F7B-339E-481A-95D8-C8B4457BDC64Q37709863-C1E08AFB-3EDA-45F9-9E68-060AC53974C5Q38724499-6DAB242E-DE91-4CA3-A674-970417123F3DQ39385277-566BF2C9-1600-401E-BA84-E6B8EDCB3EB9
P2860
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
description
1967 nî lūn-bûn
@nan
1967 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1967 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
name
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@ast
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@en
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@nl
type
label
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@ast
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@en
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@nl
prefLabel
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@ast
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@en
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@nl
P2860
P356
P1476
Alper CA, Rosen FS: Studies of ...... normal subjects and patients.
@en
P2093
P2860
P304
P356
10.1172/JCI105691
P407
P577
1967-12-01T00:00:00Z